Olmiza (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxomil, the active ingredient in Olmiza, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults. GNH USA supplies Olmiza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmiza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmiza is a combination antihypertensive that acts on the renin‑angiotensin system and calcium‑channel pathways to lower blood pressure. - Hypertension: helps achieve target blood pressure levels in adults. - Chronic kidney disease with hypertension: assists in slowing disease progression by controlling blood pressure. - Heart failure with reduced ejection fraction: used as part of a regimen to reduce cardiac workload.

Side effects may occur with any antihypertensive therapy.

Common Side Effects: - Dizziness - Headache - Peripheral edema - Flushing - Fatigue - Nasal congestion

Serious or Rare Side Effects: - Angio‑angio - Severe hypotension - Hepatic injury - Acute kidney injury - Myocardial infarction - Life‑threatening arrhythmias

When ​  ​    ​       ​      ​          ​    ​ ​                     ​         ​ …   … … … … … …. Sorry       …  … …  … … ...  … … … … … … … … … … … … … """"  ");

The     ");"  "" "